CO2;5 and (iii) insertion of CO2 into the aziridines moiety.6
Methods ii and iii utilizing CO2 as a feedstock, which is an
abundant, nontoxic, and cheap C1 building block, are promising
from a green chemistry perspective.7 In this respect, numerous
homogeneous catalysts have currently been developed for the
cycloaddition reaction of aziridines to CO2, such as a dual-
component system, viz., SalenCr(III)/DMAP6f or Phenol/
DMAP,6g alkali metal halide,6c–e or the tetraalkylammonium
halide system.6d Particularly, iodine was extremely active for
this reaction under supercritical CO2 (scCO2) conditions.6b,h In
addition, the cycloaddition of aziridines to CO2 also proceeded
smoothly under electrochemical reaction conditions.6a Nonethe-
less, toxic organic solvents and cocatalysts are generally required
to achieve high yields, along with a limited substrate scope in
those above-mentioned cases. Therefore, the recyclability of the
catalysts and product separation and developing highly effective
catalysts for regioselective synthesis of 5-substituted-2-oxazoli-
nones are still important issues to be addressed.
Quaternary Ammonium Bromide Functionalized
Polyethylene Glycol: A Highly Efficient and
Recyclable Catalyst for Selective Synthesis of
5-Aryl-2-oxazolidinones from Carbon Dioxide
and Aziridines Under Solvent-Free Conditions
Ya Du, Ying Wu, An-Hua Liu, and Liang-Nian He*
State Key Laboratory and Institute of Elemento-Organic
Chemistry, Nankai UniVersity, Tianjin 300071,
People’s Republic of China
ReceiVed February 2, 2008
As catalyst recycling is often a vital problem in homogeneous
catalysis efficient recycling concepts have to be developed. To
preserve the benefits of a homogeneous catalyst while co-opting
the primary benefits of a heterogeneous catalyst, one strategy
is to graft the active species onto an insoluble support, whereby
the catalyst can be readily separated from the reaction mixture
by filtration. Notably, An appealing methodology would employ
a CO2-philic support for the reaction such that the supported
catalyst dissolves during the reaction and can precipitate
quantitatively at the separation stage. The most commonly used
parameters to induce the precipitation are temperature, solvent,
polarity, and pH of the solution. In this context, PEG should
be an excellent candidate, being regarded as an environmentally
benign medium for chemical reactions.8 We envisioned that a
functionalized PEG, with a quaternary ammonium salt as a
catalytically active species being covalently grafted onto PEG,
could be utilized as an active and recyclable homogeneous
catalyst for oxazolidinone synthesis from aziridine and CO2. In
A quaternary ammonium bromide covalently bound to
polyethylene glycol (PEG, MW ) 6000), i.e., PEG6000
-
(NBu3Br)2, was found to be an efficient and recyclable
catalyst for the cycloaddition reaction of aziridines to CO2
under mild conditions without utilization of additional
organic solvents or cocatalysts. As a result, 5-aryl-2-oxazo-
lidinone was obtained in high yield with excellent regiose-
lectivity. The catalyst worked well for a wide variety of
1-alkyl-2-arylaziridines. Besides, the catalyst could be re-
covered by centrifugation and reused without significant loss
of catalytic activity and selectivity.
(4) Selected examples for condensation of amino alcohols with carbonyl
derivatives to afford oxazolidinones, see: (a) Crowther, H. L.; McCombie, H.
J. Chem. Soc. 1913, 103, 27. (b) Close, W. J. J. Am. Chem. Soc. 1951, 73, 95.
(c) Ben-Ishai, D. J. Am. Chem. Soc. 1956, 78, 4962. (d) Vo, L.; Ciula, J.;
Gooding, O. W. Org. Process Res. DeV. 2003, 7, 514. Oxazolidinones synthesis
by direct addition of carbon dioxide or carbon monoxide to ꢀ-amino alcohols,
see: (e) Steele, A. B. U.S. Patent 2 868 801, 1959. (f) Lynn, J. W. U.S. Patent
2 975 187, 1961. (g) Yoshida, T; Kambe, N.; Ogawa, A; Sonoda, N. Phosphorus
Sulfur 1988, 38, 137.
Oxazolidinones are important heterocyclic compounds show-
ing a large application as intermediates1 and chiral auxiliaries2
in organic synthesis. Cyclic carbamates like 5-substituted
oxazolidinones are often employed as fragments in biologically
active materials for pharmaceutical and agricultural uses.3 There
are three main synthetic strategies starting from C1 resources:
(i) carbonylation of amino alcohols with phosgene, CO, etc.;4
(ii) reaction of propargylamines or propargylic alcohols with
(5) Selected examples concerning the reaction of propargylamines with carbon
dioxide to afford oxazolidinones, see: (a) Costa, M.; Chiusoli, G. P.; Rizzardi,
M. Chem. Commun. 1996, 1699. (b) Shi, M.; Shen, Y. M. J. Org. Chem. 2002,
67, 16. (c) Feroci, M.; Orsini, M.; Sotgiu, G.; Rossi, L.; Inesi, A. J. Org. Chem.
2005, 70, 7795. (d) Kayaki, Y.; Yamamoto, M.; Suzuki, T.; Ikariya, T. Green
Chem. 2006, 8, 1019. Reaction of propargylic alcohols and amines to give
oxazolidinones, see: (e) Gu, Y. L.; Zhang, Q. H.; Duan, Z. Y.; Zhang, J.; Zhang,
S. G.; Deng, Y. Q. J. Org. Chem. 2005, 70, 7376.
(1) For selected examples with oxazolidinones as intermediates, see: (a)
Watson, R. J.; Batty, D.; Baxter, A. D.; Hannah, D. R.; Owen, D. A.; Montana,
J. G. Tetrahedron Lett. 2002, 43, 683. (b) Aurelio, L.; Brownlee, R. T. C.;
Hughus, A. B. Chem. ReV. 2004, 104, 5823. (c) Shi, Z. D.; Liu, H. P.; Zhang,
M. C.; Yang, D. J.; Burke, T. R., Jr Synth. Commun. 2004, 34, 3883. (d) Makhtar,
T. M.; Wright, G. D. Chem. ReV. 2005, 105, 529. (e) Andreou, T.; Costa, A. M.;
Esteban, L.; Gonzalez, L.; Mas, G.; Vilarrasa, J. Org. Lett. 2005, 7, 4083.
(2) For selected examples using oxazolidinones as chiral auxiliaries, see: (a)
Phoon, C. W.; Abell, C. Tetrahedron Lett. 1998, 39, 2655. (b) Prashad, M.;
Liu, Y. G.; Kim, H. Y.; Repic, O.; Blacklock, T. J. Tetrahedron: Asymmetry
1999, 10, 3479. (c) Gawley, R. E.; Campagna, S. A.; Santiago, M.; Ren, T.
Tetrahedron: Asymmetry 2002, 13, 29.
(6) The insertion of CO2 into the aziridines moiety to give oxazolidinones,
see: (a) Tascedda, P.; Dunach, E. Chem. Commun. 2000, 449. (b) Kawanami,
H.; Ikushima, Y. Tetrahedron Lett. 2002, 43, 3841. (c) Hancock, M. T.; Pinhas,
A. R. Tetrahedron Lett. 2003, 44, 5457. (d) Sudo, A.; Morioka, Y.; Koizumi,
E.; Sanda, F.; Endo, T. Tetrahedron Lett. 2003, 44, 7889. (e) Sudo, T.; Morioka,
Y.; Sanda, F.; Endo, T. Tetrahedron Lett. 2004, 45, 1363. (f) Miller, A. W.;
Nguyen, S. T. Org. Lett. 2004, 6, 2301. (g) Shen, Y. M.; Duan, W. L.; Shi, M.
Eur. J. Org. Chem. 2004, 3080. (h) Kawanami, H.; Matsumoto, H.; Ikushima,
Y. Chem. Lett. 2005, 34, 60. (i) Ihata, O.; Kayaki, Y.; Ikariya, T. Angew. Chem.,
Int. Ed. 2004, 43, 717.
(3) (a) Brickner, S. J. Curr. Pharm. Des. 1996, 2, 175. (b) Barbachyn, M. R.;
Ford, C. W. Angew. Chem, Int. Ed. 2003, 42, 2010. (c) Nilus, A. M. Curr. Opin.
InVest. Drugs. 2003, 4, 149.
(7) Sakakura, T.; Choi, J. C.; Yasuda, H. Chem. ReV. 2007, 107, 2365.
10.1021/jo800269v CCC: $40.75
Published on Web 05/13/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 4709–4712 4709